For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
LPI (LP Information)' newest research report, the "Artificial Organ Bank Industry Forecast" looks at past sales and reviews total world Artificial Organ Bank sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Organ Bank sales for 2023 through 2029. With Artificial Organ Bank sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Organ Bank industry.
This Insight Report provides a comprehensive analysis of the global Artificial Organ Bank landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Organ Bank portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artificial Organ Bank market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Organ Bank and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Organ Bank.
The global Artificial Organ Bank market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Artificial Organ Bank is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artificial Organ Bank is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artificial Organ Bank is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artificial Organ Bank players cover Berlin Heart Gmbh, Second Sight Medical Product types, Boston Scientific Corporation, Biomet Inc., Edwards Lifesciences Corporation, Ekso Bionics, Jarvik Heart Inc., Lifenet Health and Medtronic Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Organ Bank market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Mechanical Bionics
- Electronic Bionics
Segmentation by application
- Artificial
- Bionics
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Berlin Heart Gmbh
- Second Sight Medical Product types
- Boston Scientific Corporation
- Biomet Inc.
- Edwards Lifesciences Corporation
- Ekso Bionics
- Jarvik Heart Inc.
- Lifenet Health
- Medtronic Inc.
- Nano Retina
- Asahi Kasei Kuraray Medical Co. Ltd. among others.
- Heartware International